149 related articles for article (PubMed ID: 10513855)
1. Cognitive effects of paroxetine in older depressed patients.
Nebes RD; Pollock BG; Mulsant BH; Butters MA; Zmuda MD; Reynolds CF
J Clin Psychiatry; 1999; 60 Suppl 20():26-9. PubMed ID: 10513855
[TBL] [Abstract][Full Text] [Related]
2. Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients.
Cassano GB; Puca F; Scapicchio PL; Trabucchi M;
J Clin Psychiatry; 2002 May; 63(5):396-402. PubMed ID: 12019663
[TBL] [Abstract][Full Text] [Related]
3. Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients.
Ferguson JM; Wesnes KA; Schwartz GE
Int Clin Psychopharmacol; 2003 Jan; 18(1):9-14. PubMed ID: 12490769
[TBL] [Abstract][Full Text] [Related]
4. Effects of nortriptyline and paroxetine on postural sway in depressed elderly patients.
Mamo DC; Pollock BG; Mulsant B; Houck PR; Bensasi S; Miller MC; Redfern MS; Reynolds III CF
Am J Geriatr Psychiatry; 2002; 10(2):199-205. PubMed ID: 11925281
[TBL] [Abstract][Full Text] [Related]
5. Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine.
Nebes RD; Pollock BG; Houck PR; Butters MA; Mulsant BH; Zmuda MD; Reynolds CF
J Psychiatr Res; 2003; 37(2):99-108. PubMed ID: 12842163
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.
Keller MB; Ryan ND; Strober M; Klein RG; Kutcher SP; Birmaher B; Hagino OR; Koplewicz H; Carlson GA; Clarke GN; Emslie GJ; Feinberg D; Geller B; Kusumakar V; Papatheodorou G; Sack WH; Sweeney M; Wagner KD; Weller EB; Winters NC; Oakes R; McCafferty JP
J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):762-72. PubMed ID: 11437014
[TBL] [Abstract][Full Text] [Related]
7. Serotonin reuptake inhibitor-related extrapyramidal side effects in two patients with cerebral palsy.
Rone LA; Ferrando SJ
Psychosomatics; 1996; 37(2):165-6. PubMed ID: 8742546
[No Abstract] [Full Text] [Related]
8. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.
Weihs KL; Settle EC; Batey SR; Houser TL; Donahue RM; Ascher JA
J Clin Psychiatry; 2000 Mar; 61(3):196-202. PubMed ID: 10817105
[TBL] [Abstract][Full Text] [Related]
9. A controlled trial of antidepressants in patients with Parkinson disease and depression.
Menza M; Dobkin RD; Marin H; Mark MH; Gara M; Buyske S; Bienfait K; Dicke A
Neurology; 2009 Mar; 72(10):886-92. PubMed ID: 19092112
[TBL] [Abstract][Full Text] [Related]
10. A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome.
Mulsant BH; Pollock BG; Nebes RD; Miller MD; Little JT; Stack J; Houck PR; Bensasi S; Mazumdar S; Reynolds CF
J Clin Psychiatry; 1999; 60 Suppl 20():16-20. PubMed ID: 10513853
[TBL] [Abstract][Full Text] [Related]
11. Risk of Dementia Among Elderly Nursing Home Patients Using Paroxetine and Other Selective Serotonin Reuptake Inhibitors.
Bali V; Chatterjee S; Carnahan RM; Chen H; Johnson ML; Aparasu RR
Psychiatr Serv; 2015 Dec; 66(12):1333-40. PubMed ID: 26234334
[TBL] [Abstract][Full Text] [Related]
12. Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder.
Herzallah MM; Moustafa AA; Natsheh JY; Danoun OA; Simon JR; Tayem YI; Sehwail MA; Amleh I; Bannoura I; Petrides G; Myers CE; Gluck MA
J Affect Disord; 2013 Nov; 151(2):484-492. PubMed ID: 23953023
[TBL] [Abstract][Full Text] [Related]
13. Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man.
Schmitt JA; Ramaekers JG; Kruizinga MJ; van Boxtel MP; Vuurman EF; Riedel WJ
J Psychopharmacol; 2002 Sep; 16(3):207-14. PubMed ID: 12236626
[TBL] [Abstract][Full Text] [Related]
14. Paroxetine-related tremor.
Lai H; Tolat R
Geriatrics; 2005 Jul; 60(7):18-20. PubMed ID: 16026177
[No Abstract] [Full Text] [Related]
15. Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline.
Pollock BG; Mulsant BH; Nebes R; Kirshner MA; Begley AE; Mazumdar S; Reynolds CF
Am J Psychiatry; 1998 Aug; 155(8):1110-2. PubMed ID: 9699704
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors.
Rozzini L; Chilovi BV; Conti M; Bertoletti E; Zanetti M; Trabucchi M; Padovani A
Int Psychogeriatr; 2010 Feb; 22(1):114-9. PubMed ID: 19552831
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of SSRI response.
Salzman C
Harv Rev Psychiatry; 1996; 4(4):215-7. PubMed ID: 9384996
[No Abstract] [Full Text] [Related]
18. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
[TBL] [Abstract][Full Text] [Related]
19. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors.
Artigas F; Perez V; Alvarez E
Arch Gen Psychiatry; 1994 Mar; 51(3):248-51. PubMed ID: 8122960
[No Abstract] [Full Text] [Related]
20. Hyponatremia associated with paroxetine.
Leung VP; Chiu HF; Lam LC
Pharmacopsychiatry; 1998 Jan; 31(1):32-4. PubMed ID: 9524983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
